{"id":"https://openalex.org/W2808874540","doi":"https://doi.org/10.1212/wnl.88.16_supplement.p6.353","title":"Durable efficacy of cladribine tablets in patients with multiple sclerosis: analysis of relapse rates and relapse-free patients in the CLARITY and CLARITY Extension studies (P6.353)","display_name":"Durable efficacy of cladribine tablets in patients with multiple sclerosis: analysis of relapse rates and relapse-free patients in the CLARITY and CLARITY Extension studies (P6.353)","publication_year":2017,"publication_date":"2017-04-18","ids":{"openalex":"https://openalex.org/W2808874540","doi":"https://doi.org/10.1212/wnl.88.16_supplement.p6.353","mag":"2808874540"},"language":"en","primary_location":{"id":"doi:10.1212/wnl.88.16_supplement.p6.353","doi":"https://doi.org/10.1212/wnl.88.16_supplement.p6.353","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.88.16_supplement.p6.353","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5066796645","display_name":"Per Soelberg S\u00f8rensen","orcid":"https://orcid.org/0000-0002-2818-3780","observed_orcids":["https://orcid.org/0000-0002-2818-3780"]},"institutions":[{"id":"https://openalex.org/I124055696","display_name":"University of Copenhagen","ror":"https://ror.org/035b05819","country_code":"DK","type":"education","lineage":["https://openalex.org/I124055696"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"Per Soelberg-Sorensen","raw_affiliation_strings":["Department of Neurology, University of Copenhagen Copenhagen Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, University of Copenhagen Copenhagen Denmark","institution_ids":["https://openalex.org/I124055696"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015754502","display_name":"Gavin Giovannoni","orcid":"https://orcid.org/0000-0001-9995-1700","observed_orcids":["https://orcid.org/0000-0001-9995-1700"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I4405263501","display_name":"Blizard Institute","ror":"https://ror.org/01y7pzx08","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405263501"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Gavin Giovannoni","raw_affiliation_strings":["Queen Mary University of London and Blizard Institute Barts and The London School of Medicine and Dentistry London United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Queen Mary University of London and Blizard Institute Barts and The London School of Medicine and Dentistry London United Kingdom","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4405263501"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110202258","display_name":"Giancarlo Comi","orcid":"https://orcid.org/0000-0002-6989-1054","observed_orcids":["https://orcid.org/0000-0002-6989-1054"]},"institutions":[{"id":"https://openalex.org/I154387261","display_name":"Vita-Salute San Raffaele University","ror":"https://ror.org/01gmqr298","country_code":"IT","type":"education","lineage":["https://openalex.org/I154387261"]},{"id":"https://openalex.org/I4210133214","display_name":"IRCCS Ospedale San Raffaele","ror":"https://ror.org/039zxt351","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210133214","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giancarlo Comi","raw_affiliation_strings":["Department of Neurology and Institute of Experimental Neurology, Universit\u00e0 Vita-Salute San Raffaele, Ospedale San Raffaele Milan Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology and Institute of Experimental Neurology, Universit\u00e0 Vita-Salute San Raffaele, Ospedale San Raffaele Milan Italy","institution_ids":["https://openalex.org/I154387261","https://openalex.org/I4210133214"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112195496","display_name":"Stuart D. Cook","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I102322142","display_name":"Rutgers, The State University of New Jersey","ror":"https://ror.org/05vt9qd57","country_code":"US","type":"education","lineage":["https://openalex.org/I102322142"]},{"id":"https://openalex.org/I4402554120","display_name":"Rutgers New Jersey Medical School","ror":"https://ror.org/014ye1258","country_code":"US","type":"education","lineage":["https://openalex.org/I102322142","https://openalex.org/I4390039302","https://openalex.org/I4402554120"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stuart Cook","raw_affiliation_strings":["Rutgers, The State University of New Jersey, New Jersey Medical School Newark NJ United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rutgers, The State University of New Jersey, New Jersey Medical School Newark NJ United States","institution_ids":["https://openalex.org/I102322142","https://openalex.org/I4402554120"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049696879","display_name":"Kottil W Rammohan","orcid":"https://orcid.org/0000-0003-2467-4280","observed_orcids":["https://orcid.org/0000-0003-2467-4280"]},"institutions":[{"id":"https://openalex.org/I4210109577","display_name":"Ohio State University Hospital","ror":"https://ror.org/020yh1f96","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2802841970","https://openalex.org/I4210109577"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kottil Rammohan","raw_affiliation_strings":["Ohio State University Hospital Columbus OH United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ohio State University Hospital Columbus OH United States","institution_ids":["https://openalex.org/I4210109577"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Peter Rieckmann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210147328","display_name":"Sozialstiftung Bamberg","ror":"https://ror.org/04pa5pz64","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210147328"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Peter Rieckmann","raw_affiliation_strings":["Neurologische Klinik, Akademisches Krankenhaus Sozialstiftung Bamberg Bamberg Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurologische Klinik, Akademisches Krankenhaus Sozialstiftung Bamberg Bamberg Germany","institution_ids":["https://openalex.org/I4210147328"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025462803","display_name":"Patrick Vermersch","orcid":"https://orcid.org/0000-0003-0997-8817","observed_orcids":["https://orcid.org/0000-0003-0997-8817"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I2279609970","display_name":"Universit\u00e9 de Lille","ror":"https://ror.org/02kzqn938","country_code":"FR","type":"education","lineage":["https://openalex.org/I2279609970"]},{"id":"https://openalex.org/I3018718406","display_name":"Centre Hospitalier Universitaire de Lille","ror":"https://ror.org/02ppyfa04","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018718406"]},{"id":"https://openalex.org/I4210128436","display_name":"Lille Inflammation Research International Center","ror":"https://ror.org/03c3m6m66","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I2279609970","https://openalex.org/I3018718406","https://openalex.org/I4210093160","https://openalex.org/I4210128436","https://openalex.org/I4387152267"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Patrick Vermersch","raw_affiliation_strings":["Univ. Lille, CHU de Lille, LIRIC - INSERM U995 Lille France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ. Lille, CHU de Lille, LIRIC - INSERM U995 Lille France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I2279609970","https://openalex.org/I3018718406","https://openalex.org/I4210128436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000898624","display_name":"Christine Hicking","orcid":"https://orcid.org/0009-0002-7750-8892","observed_orcids":["https://orcid.org/0009-0002-7750-8892"]},"institutions":[{"id":"https://openalex.org/I164928964","display_name":"Merck KGaA, Darmstadt (Germany)","ror":"https://ror.org/04b2dty93","country_code":"DE","type":"company","lineage":["https://openalex.org/I164928964"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Christine Hicking","raw_affiliation_strings":["Merck KGaA Darmstadt Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck KGaA Darmstadt Germany","institution_ids":["https://openalex.org/I164928964"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025957243","display_name":"Abidemi K. Adeniji","orcid":"https://orcid.org/0000-0002-8882-5079","observed_orcids":["https://orcid.org/0000-0002-8882-5079"]},"institutions":[{"id":"https://openalex.org/I4210111614","display_name":"EMD Serono, Inc. (United States)","ror":"https://ror.org/027zrs220","country_code":"US","type":"company","lineage":["https://openalex.org/I164928964","https://openalex.org/I4210111614"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Abidemi Adeniji","raw_affiliation_strings":["EMD Serono, Inc. Billerica MA United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EMD Serono, Inc. Billerica MA United States","institution_ids":["https://openalex.org/I4210111614"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5010771032","display_name":"Fernando Dangond","orcid":"https://orcid.org/0000-0002-6723-4229","observed_orcids":["https://orcid.org/0000-0002-6723-4229"]},"institutions":[{"id":"https://openalex.org/I4210111614","display_name":"EMD Serono, Inc. (United States)","ror":"https://ror.org/027zrs220","country_code":"US","type":"company","lineage":["https://openalex.org/I164928964","https://openalex.org/I4210111614"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Fernando Dangond","raw_affiliation_strings":["EMD Serono, Inc. Billerica MA United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"EMD Serono, Inc. Billerica MA United States","institution_ids":["https://openalex.org/I4210111614"]}]}],"institutions":[],"countries_distinct_count":6,"institutions_distinct_count":15,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.28209375,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"88","issue":"16_supplement","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11827","display_name":"Polyomavirus and related diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cladribine-tablets","display_name":"cladribine tablets","score":0.9739999771118164},{"id":"https://openalex.org/keywords/relapsing-multiple-sclerosis","display_name":"relapsing multiple sclerosis","score":0.9860000014305115},{"id":"https://openalex.org/keywords/relapse-rate","display_name":"relapse rate","score":0.8379999995231628},{"id":"https://openalex.org/keywords/relapse-free-survival","display_name":"relapse-free survival","score":0.8769999742507935},{"id":"https://openalex.org/keywords/long-term-treatment-efficacy","display_name":"long-term treatment efficacy","score":0.7289999723434448},{"id":"https://openalex.org/keywords/extension-study","display_name":"extension study","score":0.6129999756813049},{"id":"https://openalex.org/keywords/placebo-controlled-comparison","display_name":"placebo comparison","score":0.4690000116825104}],"concepts":[{"id":"https://openalex.org/C2777146004","wikidata":"https://www.wikidata.org/wiki/Q14949826","display_name":"CLARITY","level":2,"score":0.9549441337585449},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7588208913803101},{"id":"https://openalex.org/C2779200787","wikidata":"https://www.wikidata.org/wiki/Q414030","display_name":"Cladribine","level":2,"score":0.7395493388175964},{"id":"https://openalex.org/C2780640218","wikidata":"https://www.wikidata.org/wiki/Q8277","display_name":"Multiple sclerosis","level":2,"score":0.4250299334526062},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.33480820059776306},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3212609887123108},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.2817588448524475},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1212/wnl.88.16_supplement.p6.353","doi":"https://doi.org/10.1212/wnl.88.16_supplement.p6.353","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.88.16_supplement.p6.353","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2774466080","https://openalex.org/W2588492167","https://openalex.org/W3162840220","https://openalex.org/W4293109336","https://openalex.org/W2998550462","https://openalex.org/W2751578374","https://openalex.org/W2998137352","https://openalex.org/W2790446387","https://openalex.org/W2104301864","https://openalex.org/W2904884305"],"abstract_inverted_index":{"Objective:":[0],"To":[1],"assess":[2],"the":[3,28,107,199,295,378,384],"efficacy":[4],"of":[5,91,191,297,341,348,436],"2-year\u2019s":[6],"additional":[7,269],"treatment":[8,109,273],"with":[9,18,113,213,230,315,397,463,494,526,570,599,628,644,659],"cladribine":[10],"tablets":[11],"(CT)":[12],"or":[13,73,83,480,514,551],"placebo":[14],"(PBO)":[15],"in":[16,23,59,75,116,120,126,131,137,142,147,152,160,170,175,180,193,210,215,220,244,248,260,264,274,282,287,334,353,431],"patients":[17,54,92,111,171,192,211,240,278],"relapsing":[19],"multiple":[20],"sclerosis":[21],"(RMS)":[22],"an":[24,335,483,634,649,664],"extension":[25],"(EXT)":[26],"to":[27,63,80,285],"CLARITY":[29,52,60,76,102,104,117,121,127,132,138,143,148,153,165,167,176,181,188,204,206,216,221,229,231,245,249,261,265,275,288,300,303],"study.":[30],"Background:":[31],"In":[32,51],"CLARITY,":[33,283],"giving":[34],"CT":[35,64,71,81,114,124,129,135,140,150,178,218,235,243,259,263,272,286],"annually":[36],"for":[37,164,313,338,395,421,461,492,524,568,597,626,642,657],"2":[38],"years,":[39],"significantly":[40,290],"reduced":[41,291],"relapse":[42,86,94,197,253],"rates":[43,87,254],"and":[44,89,118,128,139,149,177,205,217,246,262,293,324,326,350,383,419,438,453,506,542,589,606,617],"slowed":[45],"disability":[46],"progression":[47],"vs":[48],"PBO.":[49,84],"Design/Methods:":[50],"EXT,":[53,189],"who":[55,69,172,241,257,279],"had":[56],"received":[57,70,173,242,258,280,310,331,359,392,426,444,458,489,521,556,565,594,611,623,639,654],"PBO":[58,119,146,174,214,247,281],"were":[61,77,96,162],"assigned":[62],"3.5mg/kg":[65,82,115,125,130,141,151,179,219],"body":[66],"weight;":[67],"those":[68],"(3.5":[72],"5.25mg/kg)":[74],"re-randomized":[78],"(2:1)":[79],"Annualized":[85],"(ARR)":[88],"proportions":[90],"qualifying":[93],"free":[95],"compared":[97],"at":[98],"different":[99],"times":[100],"(i.e.":[101],"vs.":[103,166,184,224,271],"EXT)":[105],"within":[106],"same":[108],"groups:":[110],"treated":[112,212],"EXT":[122,133,144,154,168,182,207,222,232,250,266,289,304],"(n=98);":[123],"(n=186);":[134,145],"5.25mg/kg":[136],"(n=244).":[155],"Results:":[156],"No":[157],"significant":[158,201],"differences":[159],"ARR":[161,292],"seen":[163,209],"except":[169],"(0.26":[183],"0.10,":[185],"p<0.0001).":[186,226],"During":[187],">70%":[190],"each":[194],"group":[195],"qualified":[196],"free;":[198],"only":[200],"difference":[202],"between":[203],"was":[208],"(58.0%":[223],"79.6%,":[225],"Conclusions:":[227],"Comparing":[228],"demonstrates":[233],"that":[234],"produced":[236],"durable":[237],"clinical":[238],"benefits:":[239],"maintained":[251],"low":[252],"throughout.":[255],"Patients":[256],"showed":[267],"no":[268],"benefit":[270],"only.":[276],"For":[277],"switching":[284],"increased":[294],"proportion":[296],"relapse-free":[298],"patients.":[299],"study:":[301],"NCT00213135,":[302],"study:NCT00641537.":[305],"Disclosure:":[306],"Dr.":[307,328,356,389,423,441,486,518,553,562,591,608,620,636,651],"Soelberg-Sorensen":[308,329,357],"has":[309,330,358,391,425,443,457,488,520,555,564,593,610,622,638,653],"personal":[311,332,393,427,459,490,522,566,595,624,640,655],"compensation":[312,333,394,428,460,491,523,567,596,625,641,656],"activities":[314,396,462,493,525,569,598,627,643,658],"Biogen":[316,363,502,529,574,616],"Idec,":[317,364,503,530,575],"Merck":[318,367,408,450,471,495,540,629],"Serono,":[319,368,409,451,472,496,528,541,646,661],"Novartis,":[320,373,410,464,534,578],"Genmab,":[321],"TEVA,":[322,369],"Elan,":[323],"GlaxoSmithKline,":[325,405],"Bayer.":[327],"editorial":[336],"capacity":[337,435],"European":[339,346],"Journal":[340,347],"Neurology,":[342,349],"Multiple":[343,380],"Sclerosis":[344,381],"Journal,":[345],"Therapeutic":[351],"Advances":[352],"Neurological":[354],"Disorders.":[355,440],"research":[360,445,557,612],"support":[361,446,558,613],"from":[362,429,447,559,614],"Bayer":[365,399,497,538,560,571],"Schering,":[366],"Baxter,":[370],"Sanofi-Aventis,":[371,499,531,584],"BioMS,":[372],"Bayer,":[374,473],"RoFAR,":[375],"Roche,":[376,414,601,615],"Genzyme,":[377,404,470,605],"Danish":[379,385],"Society,":[382],"Medical":[386],"Research":[387],"Council.":[388],"Giovannoni":[390,424,442],"AbbVie,":[398],"HealthCare,":[400,498],"Biogen,":[401,448,600],"Canbex,":[402],"FivePrime,":[403],"GW":[406],"Pharma,":[407,573],"Protein":[411],"Discovery":[412],"Laboratories,":[413],"Synthon,":[415],"Teva":[416,465,504,535,581],"Neuroscience,":[417],"UCB,":[418],"Vertex":[420],"honoraria.":[422],"Elsevier":[430],"a":[432,477,511,546],"co-chief":[433],"editor":[434],"MS":[437],"Related":[439],"Ironwood,":[449],"Merz,":[452],"Novartis.":[454],"Prof.":[455],"Comi":[456],"Pharmaceutical":[466,582],"Ind.":[467],"Ltd,":[468],"Sanofi,":[469],"Actelion":[474],"Sano":[475],"as":[476,510,545,633,648,663],"speaker,":[478,547],"consultant":[479],"participating":[481],"on":[482],"advisory":[484,515],"board.":[485],"Cook":[487],"Neurology":[500],"Reviews,":[501],"Pharmaceuticals,":[505],"Actinobac":[507],"Biomed":[508],"Inc.,":[509],"lecturer,":[512],"consultant,":[513],"board":[516],"member.":[517],"Rammohan":[519,554],"EMD":[527,645,660],"Genzyme":[532],"Corporation,":[533],"Neurosciences,":[536],"Acorda,":[537],"Healthcare,":[539],"Roche/Genentech":[543],"Inc.":[544,647,662],"steering":[548],"committee":[549],"member,":[550],"consultant.":[552],"Healthcare.":[561],"Rieckmann":[563],"Schering":[572],"Boehringer":[576],"Ingelheim,":[577],"Merck-Serono,":[579],"Teva,":[580,603],"Industries,":[583],"Serono":[585],"Symposia":[586],"International":[587],"Foundation":[588],"Genzyme.":[590,619],"Vermersch":[592,609],"Merck,":[602],"Sanofi":[604,618],"Almirall.":[607],"Hicking":[621],"KGaA,":[630],"Darmstadt,":[631],"Germany":[632],"employee.":[635,650,665],"Adeniji":[637],"Dangond":[652]},"counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2018-06-29T00:00:00"}